Stop the pain: Tips for increasing patient retention and decreasing missing data in analgesia clinical trials
Rho
| « Previous month | Next month » |
TNT Express is now offering temperature-controlled logistics services to support global distribution of biologics.
Sponsors want CROs to join the debate on quality management in clinical research says the Avoca Group, which has invited contractors to sign up to its recently established industry consortium.
Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.
Parexel posted double-digit revenue growth and record backlog in its second quarter, but rising costs drove down profits.
Russia’s trial sector has largely recovered from the ‘crisis’ created by revision of approval system in 2010, but regulators are still taking too long to OK studies says industry group ACTO.
Lpath has suspending dosing in its iSONEP clinical trials after learning the CMO handling fill and finish has cGMP failings.
HUYA Bioscience says it will strengthen bonds between Chinese drug innovators and worldwide developers and through its new partnership with the Tianjin Institute of Pharmaceutical Research (TIPR).
Covance could cut early development capacity if the unit posts flat sales in the coming fiscal year, its CEO said.
Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Patheon, Wolfe Laboratories, and Premier Research.
Covance is accelerating IT investment faster and for longer than expected, resulting in 2012 guidance that met analysts’ “worst-case fears”.
Outsourcing-Pharma presents a round-up of the latest headlines within the world of contract manufacturing. Catalent and Patheon have each launched oral dosage partnership news, whilst Frontage and AMPAC have received regulatory go-aheads.
Jubilant Life Sciences has bought US drugmaker Eli Lilly’s stake in the early-stage development focused JV the firms set up in 2008.
DHL has obtained a license for packaging, labelling and storing medical devices at its logistics site in Tokyo, Japan.
Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.
Clinical Financial Services (CFS) has made its first foray into the global market after opening a new office in Edinburgh, Scotland.
A patent loss-fuelled surge in big pharma outsourcing will push the European CMO market through the $20bn barrier by 2018, analysis claims.
Lonza has fired its CEO after a halving of net income prompted the board to find another leader for “the challenging years ahead”.
UK-based ProTrials Research will expand a new subsidiary in a bid to meet its clients increasing demands for a wider range of multi-national clinical trials.
Preclinical CROs begin reporting full year results this week, with talk of takeovers and toxicology high on agendas.
Outsourcing-Pharma presents a roundup of eClinical technology news, including “omnics” at Oracle and DDi at DIA.
Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
Multilingual ‘magic’ and cultural knowledge are the keys to business process outsourcing (BPO) success in North Asia according to Quintiles.
UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
Almac says its isotope chemistry facility and its lab division both passed UK regulators’ inspections.
Acurian says rapid expansion of its opt-in trial subject database is testament to the efficacy of direct-to-patient communication.
SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .
InVentiv will boost its market research and analytics offering with the acquisition of SDI’s medical audit activities.
Pharmaceutics International, Inc (Pii) is to double its sterile GMP production capacity by building a 24,000 sq ft facility.
Outsourcing-Pharma presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from Premier Research, Almac, and AAI Pharma.
The EMA has warned sponsors must take “great care” when outsourcing to niche subcontractors to avoid violating GCP.
Clinical research associates (CRAs) spend less than half of their time conducting ‘on site’ monitoring with training, travel and admin taking up the majority of their time according to new research
Quintiles has invested £3m ($4.6m) in a new UK-based biomarker R&D company in a continuation of its efforts to build in the field of personalised medicines.
Training and consultancy firm NSF Health Sciences (NSF-DBA) has acquired Pink Associates in a bid to broaden its service offering.
CMO Paragon Bioservices has won a $15m DoD contract to develop a large-scale mammalian process for a trivalent filovirus vaccine.
VivoPharm says its new agreement with primary patient-derived tumour creators EPO-GmbH will bring drug candidate selection to a “new level” for US drug researchers.
Swiss API maker Carbogen Amcis has bought French contract manufacturer Creapharm Parenterals to boost capabilities in early-phase high potency drug development.
inVentiv Health says it will now offer a one-stop-shop for pharma and biotech training services after merging its subsidiaries Pharmaceutical Institute and Preceptiv Learning Solutions.
Study payment tech firm Greenphire says partnership with Merge Healthcare’s trial arm will offer greater efficiencies for pharmaceutical industry sponsors.
J&J has enough Doxil to meet the needs of patients on its waiting list but warned CMO Ben Venue is unlikely to resume supply until late 2012.
Contract services firm Warnex will leave the Toronto Stock Exchange (TSX) after failing to meet the requirements for continued listing.
Outsourcing-Pharma presents a round-up of the latest contract manufacturing headlines in the industry, including news from Nanohale, Fleming and Trophogen.
Covance plans a ‘substantial investment’ to consolidate its international data centres and develop clinical tools to arrest expanding IT costs.
Almac has opened a new clinical services building at its HQ in Craigavon, Northern Ireland to bring together staff involved in trial supplies.
CRO Popsi Cube is using iPhones to track blood pressure data and send questionnaires to patients.
Cyprotex says bigger preclinical CROs are stuck in toxicity testing ‘time warp’, citing drug industry demand for innovative cellular methods as key to its second half performance.
Custom antibody manufacturer Cambridge Research Biochemicals (CRB) has expanded its range of labelling dyes through a new agreement with supplier Life Technologies.
Outsourcing to Indian CRAMS and bulk drug businesses will drive the country’s export growth, a credit rating agency said.
Charles River’s CEO has reiterated the importance of integrating its research models and preclinical units but refused to discuss takeover reports.
Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
Major CRO consolidation will slow down in 2012 after the big wave of deals last year, the CEO of Icon said.
ShangPharma has revealed its newly opened 100,000 sq foot facility will serve the growing capacity needs of pharma giant Eli Lilly.
US contractor Catalent Pharma Solutions’ new biologics plant will be a facility formerly owned by GE Healthcare.
Sigma-Aldrich says it is a step closer to becoming a one-stop-shop for biopharmas in the drug discovery process after it inked a takeover agreement with biological testing firm BioReliance.
Charles River is reportedly considering selling the business, with private equity and rival companies believed to be possible buyers.
A prior relationship rather than price was the most significant factor in helping Icon win its strategic deal with Shire according to an analyst who says such a trend is good for the sector.
AMRI has begun reviewing its chemistry services operation in Hungary and says it may cut jobs and shift work to other facilities.
Preclinical molecular biology services firm BioLigands has changed ownership.
Ireland-based CRO Icon will do all of Shire’s central laboratory work under a new strategic alliance announced today.
Outsourcing-Pharma presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Mylan, Aegate, and Intralinks.
European CROs Dualsystems Biotech and NiKem Research have partnered to offer drug profiling and discovery services.
Albany Molecular Research (AMRI) says ‘streamlining’ plan will focus on its drug licensing unit not its contract API research, development and manufacturing services division.
Toray Industries has acquired a stake in a Japanese CMO and ingredient supplier as part of its push into life sciences.
ACRO says latest draft rules on trials in India – which would see ethics committees take sole responsibility for determining SAE cause and compensation - are a backwards step that would make high quality research impossible.
UK-based biotech ValiRx has acquired a biomarkers business from Finnish preclinical CRO Pharmatest Services.
Biopharm companies have inked a raft of contract service deals at the start of 2012 in efforts to push compounds into the clinic.
Quintiles says it will streamline its patient recruitment model with a new digital unit.
AAIPharma Services says it will expand its contract analytics and manufacturing capacity to meet increasing customer demand.
Supply chain management company Marken has opened the doors to its new temperature-controlled clinical distribution depot in Argentina.
Publication of all clinical data and recruitment targets is needed to boost trial transparency, researchers claim.
The FDA should encourage industry to submit draft guidance to speed regulatory development, an agency working group found.
The ENCePP (European network of centres for pharmacoepidemiology and pharmacovigilance) is seeking to facilitate better interaction with biopharm companies on post-authorisation studies.
Manufacturing operations at Shasun Pharma’s plant in Cuddalore, Tamil Nadu are still suspended days after Southern India was battered by a cyclonic storm.
The clinical data interchange standards consortium (CDISC) has been designated as a charitable organisation by the US tax authorities, meaning it can now receive tax-deductible contributions from corporate donors.
US CRO PPS Clinical Research has admitted that an employee falsified patient record during a trial of Boehringer Ingelheim’s failed ‘female Viagra,’ Flibanserin.
Outsourcing-Pharma presents its first round-up of the movers and shakers within the pharmaceutical industry of 2012, including news from Icon, Marken and ClinStar.
India has released draft guidance on stability data needed to support approval of Phase I to III clinical trials.
Ben Venue Laboratories will not restart manufacturing at its plant in Bedford, Ohio until later this quarter – at the earliest - after extending the voluntary suspension it implemented in November.
| « Previous month | Next month » |